The role of hormones in muscle hypertrophy.
Fink J, Schoenfeld BJ, Nakazato K.
Phys Sportsmed. 2018 Feb;46(1):129-134. doi: 10.1080/00913847.2018.1406778. Epub 2017 Nov 25.
Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.
Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P, Sani G.
Curr Neuropharmacol. 2015 Jan;13(1):101-21. doi: 10.2174/1570159X13666141210222725.
Steroid addiction.
Kligman AM, Frosch PJ.
Int J Dermatol. 1979 Jan-Feb;18(1):23-31. doi: 10.1111/j.1365-4362.1979.tb01905.x.
The importance of translationally evaluating steroid hormone contributions to substance use.
Maher EE, Strzelecki AM, Weafer JJ, Gipson CD.
Front Neuroendocrinol. 2023 Apr;69:101059. doi: 10.1016/j.yfrne.2023.101059. Epub 2023 Feb 7.
Anabolic Androgenic Steroid Abuse: The Effects on Thrombosis Risk, Coagulation, and Fibrinolysis.
Chang S, Münster AB, Gram J, Sidelmann JJ.
Semin Thromb Hemost. 2018 Nov;44(8):734-746. doi: 10.1055/s-0038-1670639. Epub 2018 Sep 28.
Anabolic androgenic steroid abuse in the United Kingdom: An update.
Mullen C, Whalley BJ, Schifano F, Baker JS.
Br J Pharmacol. 2020 May;177(10):2180-2198. doi: 10.1111/bph.14995. Epub 2020 Mar 3.
Psychiatric complications of anabolic steroid abuse.
Hall RC, Hall RC, Chapman MJ.
Psychosomatics. 2005 Jul-Aug;46(4):285-90. doi: 10.1176/appi.psy.46.4.285.
Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes.
Christou GA, Christou MA, Žiberna L, Christou KA.
Eur J Sport Sci. 2019 Oct;19(9):1276-1286. doi: 10.1080/17461391.2019.1587522. Epub 2019 Mar 18.
[Testosterone - indications and abuse].
Köhn FM, Schuppe HC.
MMW Fortschr Med. 2024 May;166(9):49-51. doi: 10.1007/s15006-024-3839-x.
Illicit anabolic-androgenic steroid use.
Kanayama G, Hudson JI, Pope HG Jr.
Horm Behav. 2010 Jun;58(1):111-21. doi: 10.1016/j.yhbeh.2009.09.006. Epub 2009 Sep 18.
